Literature DB >> 20530801

Eradicating the mediators of neuronal death with a fine-tooth comb.

R Suzanne Zukin1.   

Abstract

Ischemic tolerance is an evolutionarily conserved form of cerebral plasticity in which a brief period of cerebral ischemia (called ischemic preconditioning) confers transient tolerance to a subsequent ischemic challenge in the brain. Polycomb group proteins are gene-silencing factors that are abundant and widely distributed during embryogenesis and are essential to epigenetic cellular memory, pluripotency, and stem cell self-renewal. New insight into the molecular mechanisms underlying ischemic tolerance is highlighted by the finding that ischemic preconditioning activates polycomb proteins in mature neurons. Polycomb proteins act through epigenetic gene silencing to eradicate potential mediators of neuronal death and promote cellular arrest, enabling mature neurons to survive ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530801      PMCID: PMC3501109          DOI: 10.1126/scisignal.3125pe20

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  36 in total

Review 1.  Neurological disease: listening to gene silencers.

Authors:  A Roopra; Y Huang; R Dingledine
Journal:  Mol Interv       Date:  2001-10

2.  Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome.

Authors:  Daphna Zaaroor-Regev; Prim de Bie; Martin Scheffner; Tahel Noy; Ruth Shemer; Maya Heled; Ilan Stein; Eli Pikarsky; Aaron Ciechanover
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 3.  Ischemic tolerance.

Authors:  Takaaki Kirino
Journal:  J Cereb Blood Flow Metab       Date:  2002-11       Impact factor: 6.200

4.  Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene.

Authors:  K Palm; N Belluardo; M Metsis; T Timmusk
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

5.  The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells.

Authors:  P Lawinger; R Venugopal; Z S Guo; A Immaneni; D Sengupta; W Lu; L Rastelli; A Marin Dias Carneiro; V Levin; G N Fuller; Y Echelard; S Majumder
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

Review 6.  Molecular genetics of human cognition.

Authors:  Edwin J Weeber; Jonathan M Levenson; J David Sweatt
Journal:  Mol Interv       Date:  2002-10

7.  Ischemic insults derepress the gene silencer REST in neurons destined to die.

Authors:  Agata Calderone; Teresa Jover; Kyung-min Noh; Hidenobu Tanaka; Hidenori Yokota; Ying Lin; Sonja Y Grooms; Roodland Regis; Michael V L Bennett; R Suzanne Zukin
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

Review 8.  Molecular adaptations for survival during anoxia: lessons from lower vertebrates.

Authors:  Philip E Bickler; Paul H Donohoe; Leslie T Buck
Journal:  Neuroscientist       Date:  2002-06       Impact factor: 7.519

9.  Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states.

Authors:  Mary P Stenzel-Poore; Susan L Stevens; Zhigang Xiong; Nikola S Lessov; Christina A Harrington; Motomi Mori; Robert Meller; Holly L Rosenzweig; Eric Tobar; Tatyana E Shaw; Xiangping Chu; Roger P Simon
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

10.  The Drosophila Polycomb group gene Sex comb on midleg (Scm) encodes a zinc finger protein with similarity to polyhomeotic protein.

Authors:  D Bornemann; E Miller; J Simon
Journal:  Development       Date:  1996-05       Impact factor: 6.868

View more
  10 in total

1.  Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Transl Stroke Res       Date:  2011-03-01       Impact factor: 6.829

Review 2.  Epigenetic mechanisms in stroke and epilepsy.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Neuropsychopharmacology       Date:  2012-08-15       Impact factor: 7.853

3.  Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death.

Authors:  Kyung-Min Noh; Jee-Yeon Hwang; Antonia Follenzi; Rodoniki Athanasiadou; Takahiro Miyawaki; John M Greally; Michael V L Bennett; R Suzanne Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

4.  Can genes modify stroke outcome and by what mechanisms?

Authors:  Roger P Simon; Robert Meller; An Zhou; David Henshall
Journal:  Stroke       Date:  2011-12-08       Impact factor: 7.914

Review 5.  The Emerging Role of Epigenetics in Cerebral Ischemia.

Authors:  Zhiping Hu; Bingwu Zhong; Jieqiong Tan; Chunli Chen; Qiang Lei; Liuwang Zeng
Journal:  Mol Neurobiol       Date:  2016-02-19       Impact factor: 5.590

Review 6.  Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications.

Authors:  Anne M Etgen; Teresa Jover-Mengual; R Suzanne Zukin
Journal:  Front Neuroendocrinol       Date:  2010-12-14       Impact factor: 8.606

Review 7.  REST, a master transcriptional regulator in neurodegenerative disease.

Authors:  Jee-Yeon Hwang; R Suzanne Zukin
Journal:  Curr Opin Neurobiol       Date:  2018-01-30       Impact factor: 6.627

Review 8.  NRSF: an angel or a devil in neurogenesis and neurological diseases.

Authors:  Zhiqi Song; Deming Zhao; Huajia Zhao; Lifeng Yang
Journal:  J Mol Neurosci       Date:  2014-12-06       Impact factor: 3.444

Review 9.  The emerging field of epigenetics in neurodegeneration and neuroprotection.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 10.  Epigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.

Authors:  David Brand; Rajiv R Ratan
Journal:  Transl Stroke Res       Date:  2013-01-08       Impact factor: 6.829

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.